Search by Drug Name or NDC
NDC 25021-0836-01 Ephedrine Sulfate 50 mg/mL Details
Ephedrine Sulfate 50 mg/mL
Ephedrine Sulfate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Sagent Pharmaceuticals. The primary component is EPHEDRINE SULFATE.
Product Information
| NDC | 25021-0836 |
|---|---|
| Product ID | 25021-836_0cced8a7-58b3-43e5-afca-2d6d3ed4c017 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Ephedrine Sulfate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ephedrine Sulfate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | mg/mL |
| Substance Name | EPHEDRINE SULFATE |
| Labeler Name | Sagent Pharmaceuticals |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA214528 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 25021-0836-01 (25021083601)
| NDC Package Code | 25021-836-01 |
|---|---|
| Billing NDC | 25021083601 |
| Package | 25 VIAL in 1 CARTON (25021-836-01) / 1 mL in 1 VIAL |
| Marketing Start Date | 2023-04-15 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |